| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/28/1993 | WO1993020816A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 10/28/1993 | WO1993020808A1 Aminoguanidine spray drying process |
| 10/28/1993 | WO1993020807A1 Amines as inhibitors of squalene synthase |
| 10/28/1993 | WO1993020696A1 Regulation of the immune system |
| 10/28/1993 | WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination |
| 10/28/1993 | CA2133090A1 Endothelin antagonists ii |
| 10/28/1993 | CA2130578A1 Taxol derivatives |
| 10/28/1993 | CA2130198A1 Method of administering pyruvate and methods of synthesizing pyruvate precursors |
| 10/28/1993 | CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them |
| 10/27/1993 | EP0567433A1 Orally-ingestible nutrition compositions having improved palatability |
| 10/27/1993 | EP0567391A1 A biodegradable tgf-beta delivery system for bone regeneration |
| 10/27/1993 | EP0567353A1 Use of 1-alpha,25-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis |
| 10/27/1993 | EP0567352A1 Use of 1-alpha,24(R)-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis |
| 10/27/1993 | EP0567088A2 Processes for the preparation of amylase inhibitor |
| 10/27/1993 | EP0566732A1 Adeno-associated virus-2 basal vectors |
| 10/27/1993 | EP0566698A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 10/27/1993 | EP0566647A1 Improved humanized immunoglobulins |
| 10/26/1993 | US5256697 Covalently linked pyruvyl-amino compound |
| 10/26/1993 | CA1323575C Use of bezafibrate for treating diabetes |
| 10/25/1993 | CA2093836A1 Biodegradable tgf-.beta. delivery system for bone regeneration |
| 10/20/1993 | EP0566535A1 Compositions comprising methanediphosphonic acids and ion-exchangers |
| 10/20/1993 | EP0566405A2 Aqueous gel retinoid dosage form |
| 10/20/1993 | EP0565683A1 Quinoxaline derivates with affinity for quisqualate-receptors |
| 10/20/1993 | EP0565634A1 Angiotensin ii receptor blocking compositions |
| 10/19/1993 | US5254715 Anticholesterol agents |
| 10/19/1993 | US5254594 Remedies for bone diseases |
| 10/19/1993 | US5254590 Acylaminophenol compounds |
| 10/19/1993 | US5254549 New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
| 10/19/1993 | US5254544 Anticholesterol |
| 10/19/1993 | CA1323367C Phenyl-substituted piperidine compounds and their preparation and use in treating calcium overload in brain cells of mammals |
| 10/14/1993 | WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems |
| 10/14/1993 | WO1993020073A1 Indole derivatives as 5-ht1 agonists |
| 10/14/1993 | WO1993020059A1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
| 10/14/1993 | WO1993019756A1 The use of quinoline-3-carboxamide compounds for treatment of diabetes |
| 10/14/1993 | DE4212529A1 Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten Use of μ-carbolines as a non-competitive glutamate antagonists |
| 10/14/1993 | CA2132624A1 Compositions and methods for regulating cellular signal transducing systems |
| 10/13/1993 | EP0565317A1 (2-(2-hydroxy-2 phenylethylamino)ethoxy) phenyl derivatives, processes and intermediates for their preparation, pharmaceutical compositions containing them and their use as Beta-3-adrenoceptor agonists |
| 10/13/1993 | EP0564804A1 Improved high protein liquid nutrition for patients with elevated wound healing requirements |
| 10/13/1993 | EP0564592A1 Liver enriched transcription factor |
| 10/12/1993 | US5252722 5-O-α-D-glucopyranosyl-L-ascorbic acid |
| 10/12/1993 | US5252707 Inositol derivative and method for preparing same |
| 10/12/1993 | US5252705 Peptide derivatives |
| 10/12/1993 | US5252604 Compositions of retinoic acids and tocopherol for prevention of dermatitis |
| 10/12/1993 | US5252571 Antidiabetic agents |
| 10/12/1993 | US5252479 Safe vector for gene therapy |
| 10/11/1993 | WO1993020820A1 USE OF β-CARBOLINES |
| 10/11/1993 | CA2117755A1 Use of .beta.-carbolines |
| 10/11/1993 | CA2093604A1 Chemical compounds |
| 10/11/1993 | CA2093453A1 High protein liquid nutrition for patients with elevated wound healing requirements |
| 10/10/1993 | CA2093777A1 Therapeutic amines |
| 10/06/1993 | EP0563731A1 Medicaments containing polyhydroxymethylene-derivatives, process for their manufacture and use thereof |
| 10/06/1993 | EP0563301A1 Alteration of rate and character of hair growth |
| 10/06/1993 | EP0563112A1 Enhanced bioavailability pharmaceutical composition containing probucol. |
| 10/06/1993 | EP0563107A1 Novel methylenebisphosphonic acid derivatives |
| 10/06/1993 | EP0563096A1 Novel methylenebisphosphonic acid derivatives |
| 10/06/1993 | CN1022325C Azolidinedione derovatives |
| 10/05/1993 | US5250524 Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 10/05/1993 | CA1322761C Organogermanium compounds and process for producing the same |
| 10/05/1993 | CA1322719C Activator for osteoblast |
| 09/30/1993 | WO1993019162A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
| 09/30/1993 | WO1993019085A1 Novel antler-derived bone growth factors |
| 09/30/1993 | WO1993019063A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 09/30/1993 | WO1993019044A1 Novel vitamin d analogues |
| 09/30/1993 | WO1993018786A1 Use of a peptide |
| 09/30/1993 | WO1993018785A1 Novel medicament |
| 09/30/1993 | WO1993018774A1 Use if estriol for treating climacteric osteoporosis |
| 09/30/1993 | WO1993018668A1 A salt product and a method for the preparation thereof |
| 09/30/1993 | CA2132219A1 Novel antler-derived bone growth factors |
| 09/30/1993 | CA2131790A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
| 09/30/1993 | CA2130195A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 09/30/1993 | CA2120703A1 Novel vitamin d analogues |
| 09/29/1993 | EP0563001A1 Imidazole compounds, their preparation and use |
| 09/29/1993 | EP0562643A2 7-Substituted-hept-6-enoic and -heptanoic acids and derivatives thereof |
| 09/29/1993 | EP0562512A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines |
| 09/29/1993 | EP0562508A2 Protein with bone formation ability and process for its production |
| 09/29/1993 | EP0562083A1 Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
| 09/29/1993 | EP0561960A1 Leukemia inhibitory factor receptors |
| 09/29/1993 | EP0561939A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 09/29/1993 | EP0561901A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
| 09/29/1993 | EP0561877A1 Compounds and compositions which inhibit bone resorption |
| 09/29/1993 | EP0561772A1 A new pharmaceutical use of fusidic acid and derivatives thereof |
| 09/29/1993 | CN1076696A Pharmaceutical compounds |
| 09/29/1993 | CN1076691A Sulfonamido-and sulfonamidocarbonyl-pyridin-2-carbonsaureamide as well as pyridin-n-oxide thereof |
| 09/28/1993 | US5248699 Hydrochloride salt, antidepressant, anorectic |
| 09/28/1993 | US5248697 For treatment of radiation associated oxidative damage in tissue |
| 09/28/1993 | US5248695 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in animal feeds |
| 09/28/1993 | US5248507 Hypertonic isochloremic formulation for circulatory shock |
| 09/28/1993 | CA2092768A1 Protein with bone formation ability and process for its production |
| 09/28/1993 | CA1322529C Dosage form of fenofibrate |
| 09/25/1993 | CA2092276A1 Sulfonamido- and sulfonamidocarbonylpyridine -2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals |
| 09/22/1993 | EP0561408A1 Agent for treatment of chronic fatigue syndrome |
| 09/22/1993 | EP0561195A1 An invigorating herbal gel for supple skin |
| 09/22/1993 | EP0561175A1 Pyrimidine derivatives and pharmaceutical compostions containing them |
| 09/22/1993 | EP0561141A1 Highly concentrated amino acid solution |
| 09/22/1993 | EP0423151B1 Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them |
| 09/21/1993 | US5247102 Cyclization of a resorcinol derivative with ethyl orthoformate in the presence of a base |
| 09/21/1993 | US5247079 Chemical intermediates for tranquilizers |
| 09/21/1993 | US5246971 Method of inhibiting nitric oxide formation |
| 09/21/1993 | US5246951 Nonsteroidal antiinflammatory agents |
| 09/21/1993 | US5246929 Prophylaxis or treatment of ischemic encephalopathia |